
![]() |
|
Marin H. Kollef, M.D., FACP, FCCP Professor of Medicine
CONTACT INFORMATION
Washington University School of Medicine EDUCATION/TRAINING
Under-Graduate Education: POSITIONS
Academic Positions/Employment: Hospital Appointments:
Director, Medical Intensive Care Unit, Fitzsimons Army Medical Center, Aurora, CO, 1988?1992 Hospital/University Committees:
BJH Critical Care Committee, 1992-present (Chairman 1994-1995, 1999-2000) Military Service: (Continuing military obligation: none)
United States Military Academy, West Point, New York; Cadet: 1975-1979 OTHER EXPERIENCE AND PROFESSIONAL MEMBERSHIPS
The Honor Society of Phi Kappa Phi, 1980 to present ACADEMIC HONORS
Academic Military
Army Service Ribbon PUBLICATIONS Kollef MH. Outcome prediction in the intensive care unit. In: The Transition from Cure to Comfort: Managing Death in the Intensive Care Unit. Curtis JR, Rubenfeld GD (eds). Oxford University Press 2000:39-57.Kollef MH. Outcomes research at the end of life. Crit Care Med 2000; 28:269-270. Kollef MH. The nonpharmacologic prevention of ventilator-associated pneumonia. In: 1999 Yearbook of Intensive Care and Emergency Medicine. Vincent JL (ed). Springer-Verlag, Berlin, 2000; 123-134. Kollef MH. A pet fancier's severe respiratory distress. Cortlandt Forum 2000; 13:176-180. Kollef MH. Selective digestive decontamination (SDD) - con view point. Crit Care and Crit Care Forum (http://ccforum.com) 2000; 4:327-332. Kollef MH. Ventilator-associated pneumonia: the importance of initial empiric antibiotic selection. Infect in Med 2000; 17:265-283. Kollef MH. The importance of adequate antimicrobial treatment for nosocomial pneumonia. Mediguide to Pulmonary Medicine 2000; 7:1-6. Kollef MH. Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31 (Suppl 4):S131-S138. Kollef MH. Improving clinical outcomes: Sometimes more is better! Lancet 2000; 356 (9234):956-957. Kollef MH. Medical trainee experience versus optimizing clinical outcomes: Achieving the best of both. Respir Care 2000; 45:938-939. Kollef MH. Antimicrobial heterogeneity: Can it help to prevent resistance? Pulmonary Perspectives 2000; 17:1-4. Kollef MH. Anaerobic bacteria are important in ventilator-associated pneumonia (VAP): Con view. Pulmonary Infections Forum 2000; IV:3-6. Kollef MH. Pulmonary Embolism. In: Pulmonary Board Review 2000. American College of Chest Physicians. Northbrook, IL 2000:425-436. Kollef MH. Hypoxic Respiratory Failure. In: Pulmonary Board Review 2000. American College of Chest Physician. Northbrook, IL 2000:517-528. Kollef MH. Critical Care. In: Manual of Medical Therapeutics. 30th Edition. Little, Brown and Company. Boston 2001; 195-215. Kollef MH. Mechanical ventilation: Protocol driven strategies. In: Ventilator Management Strategies for Critical Care. Hill NS, Levy M (eds). Marcel Dekker, Inc. 2001; 158:111-136. Kollef MH. Is there a role for antibiotic cycling in the intensive care unit? Crit Care Med 2001; 29 (Suppl 4):N135-N142. Kollef MH. The intensive care unit in antimicrobial resistance. Hospital Practice 2001:60-69. Iregui M, Kollef MH. Ventilator-associated pneumonia and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2001; 22:317-325. Kollef MH. What's new in ventilator-associated pneumonia. Anesthesiology 2001; 94:551-553. Kollef MH. Antibiotic resistance among gram-positive bacteria in the hospital setting: what can we do about it? Medscape Treatment Update: http://www.medscape.com/uptodate/2000/12.00/utd1201.14.koll/utd1201.14.koll-01.html. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Crit Care Med 2001; 29:1473-1475. Kollef MH, Niederman M. Antimicrobial resistance in the ICU: The time for action is now. Crit Care Med 2001; 29(Suppl 4):N63. Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Critical Care 2001; 5:189-195. Chakinala M, Trulock E, Kollef MH. Critical care of lung transplant recipients. J Intensive Care Med 2001 (In Press). Kollef MH. Is prevention of ventilator-associated pneumonia cost effective: A North American View. In: Infection Control in the ICU Environment. Bonten M, Weinstein RA (eds). Kluwer Academic Publishers 2002; 141-154. Ibrahim E, Kollef MH. The use of protocols to improve clinical outcomes in acute respiratory failure. Crit Care Clin 2001; 17: 989-1001. Kollef MH. Selective digestive decontamination (SDD) should not be routinely employed. Chest 2003; 123:464s-468s. Iregui M, Kollef MH. Prevention of ventilator-associated pneumonia: Selecting interventions, which make a difference Chest 2002; 121:679-681. Kollef MH. Strategies in the prevention of ventilator-associated pneumonia In: Critical Care Infectious Diseases. Rello J, Valles J, Kollef M (eds). Kluwer Academic Publishers 2001; 707-718. Kollef MH. Intensive care units and the development of resistance to antimicrobial agents. In: Infeccion 2002. Bouza E, Picato JJ (eds). Fundacion para el Estudio de la Infeccion 2002; 267-292. Ely EW, Meade MO, Haponik EF, Kollef MH, Cook DJ, Guyatt GH, Stoller JK. Mechanical ventilation weaning protocols driven by nonphysician health-care professional: evidence-based clinical practice guidelines. Chest 2001; 120: 454S-463S. Kollef MH. Prevention of ventilator-associated pneumonia. In: Perspectives in Critical Care Infectious Disease (Volume 4: Ventilator-Associated Pneumonia). Wunderink RG, Rello J (eds). Kluwer Academic Publishers 2001; 45-60. Iregui M, Kollef MH. Non-pharmacologic prevention of hospital-acquired pneumonia. Semin Respir Crit Care Med 2002; 23: 489-496. Kollef MH. Prevention of antibiotic resistance. (Letter) Ann Intern Med 2002; 136: 173. Shorr A, Kollef MH. The quick and the dead: The evaluation of pulmonary infiltrates in immunocompromised hosts. Chest 2002; 122: 9-12. lef MH. Critical care in: Manual of Medical Therapeutics. 31st Edition. Little Brown and Company. Boston 2003; (In Press). lef MH. Appropriate antibiotic therapy for VAP and sepsis: A necessity not an issue for debate. Intensive Care Med (In Press). lef MH. The diagnosis and medical management of ventilator-associated pneumonia (Monograph) (In Press). Kollef MH. Impact of inappropriate antimicrobial selection on outcome. In: Guidelines and Formulary Considerations in Infectious Disease. Owens, Ambrose, Nightingale (eds). Marcel Dekker, Inc. (In Press). Kollef MH. Lectures in hospital infections. Part one: Nosocomial pneumonia. Science Press Ltd. (In Press). Kollef MH. Appropriate empirical antibacterial therapy for nosocomial infections. Drugs (In Press). Kollef MH. An Empirical approach to treatment of multidrug-resistant ventilator-associated pneumonia. Clin Infect Dis 2003; 36:1119-1121. Warren DK, Kollef MH. Infection control and surveillance in the intensive care unit. In: Principles of Critical Care. Hall JB, Schmidt G, Wood L (eds). McGraw Hill Publishers (In Press). RESEARCH SUPPORT
Bard Medical Inc. Preventing VAP with a silver-coated endotracheal tube, (Principal Investigator) 2002-2003 Agency for Healthcare Research and Quality. Surveillance analysis and interventions to improve patient safety. 2002-2004 Department of Veteran Affairs. Intensive vs. conventional renal support in acute renal failure (Co-Principal Investigator) 2003-2005 Intrabiotics Pharmaceuticals, Inc. VAP prevention with iseganan (Principal Investigator) 2003-2004
Division of Pulmonary and Critical Care Medicine
|